The trademark application GEXTRAVIX was filed by PFIZER INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 9, 2021, and it was registered by office on June 16, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).